M
Manuela Fiuza
Researcher at University of Lisbon
Publications - 45
Citations - 534
Manuela Fiuza is an academic researcher from University of Lisbon. The author has contributed to research in topics: Myocardial infarction & Breast cancer. The author has an hindex of 11, co-authored 41 publications receiving 451 citations.
Papers
More filters
Journal ArticleDOI
Circulating miR-122-5p/miR-133b Ratio Is a Specific Early Prognostic Biomarker in Acute Myocardial Infarction.
Nuno Cortez-Dias,Marina C. Costa,Pedro Carrilho-Ferreira,Doroteia Silva,Cláudia Jorge,Carina Calisto,Teresa Pessoa,Susana Robalo Martins,João de Sousa,Pedro Canas da Silva,Manuela Fiuza,António Nunes Diogo,Fausto J. Pinto,Francisco J. Enguita +13 more
TL;DR: This study showed that the miR-122-5p/133b ratio is a new prognostic biomarker for the early identification of STEMI patients at a higher risk of developing major adverse events after undergoing primary percutaneous coronary intervention.
Journal Article
Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
Manuela Fiuza,Nuno Cortez-Dias,Susana da Cruz Martins,Adriana Belo,Valsim study investigators +4 more
TL;DR: The prevalence of MS in Portugal is high and is strongly linked to the occurrence of CVD, and in particular to DM, and the need to implement preventive strategies for reducing overall cardiovascular risk in the Portuguese population is highlighted.
Journal Article
Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study.
Nuno Cortez-Dias,Susana da Cruz Martins,Adriana Belo,Manuela Fiuza,Investigadores do estudo Valsim +4 more
TL;DR: There is considerable regional variation in treatment patterns and increasing the use of combination antihypertensive therapy would probably improve HT control in the population, as they are used less than would be expected, compared to other European countries.
Journal ArticleDOI
Cystatin C as prognostic biomarker in ST-segment elevation acute myocardial infarction.
Doroteia Silva,Nuno Cortez-Dias,Cláudia Jorge,J. Silva Marques,Pedro Carrilho-Ferreira,Andreia Magalhães,Susana Robalo Martins,Susana Gonçalves,Pedro Canas da Silva,Manuela Fiuza,António Nunes Diogo,Fausto J. Pinto +11 more
TL;DR: It is concluded that cystatin C is a new biomarker with significant added prognostic value for patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention, predicting both short- and long-term outcomes.
Journal Article
Prevalence, management and control of diabetes mellitus and associated risk factors in primary health care in Portugal.
TL;DR: The management of DM in a primary care setting in Portugal can and should be improved, since 9.8% of patients are not treated and 48.3% are not controlled.